Long-term Outcomes of Endovascular Baroreflex Amplification in Symptomatic Patients With HFrEF

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Abbott Vascular; AstraZenca; Edwards Lifesciences; Boston Scientific Corporation; Biotronik; Medtronic; Merck/Schering Plough; St. Jude Medical
• Grant Support/Research Contract - AstraZenca